Healthcare Industry Today
sign up now for free trial
FORMATS: RSS | EMAIL | MOBILE

Latest Acyclovir News

  • --> BioAlliance Pharma publishes its Q2 2008 turnover 21 Jul 2008 17:15 GMT
    ... the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, ... with BioAlliance on this file. Phase III acyclovir Lauriad® in recurrent labial herpes: We are ... application in the USA. Phase II/III doxorubicin Transdrug® trial in primary liver cancer: This quarter, ...

  • BioAlliance Pharma publishes its Q2 2008 turnover 21 Jul 2008 17:13 GMT
    ... the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, ... with BioAlliance on this file. Phase III acyclovir Lauriad® in recurrent labial herpes: We are ... application in the USA. Phase II/III doxorubicin Transdrug® trial in primary liver cancer: This quarter, ...


1 - 2 / 2

NOT SATISFIED WITH THIS ACYCLOVIR NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
REACH 1,000,000 READERS A MONTH! ADVERTISE HERE
 

Take This Poll

Regardless of your general preferences, which U.S. presidential candidate's Iraq policy do you support? (Jul. 15, 2008)



 

EIN News Copyright © 2005-2008 IPD Group, Inc. All Rights Reseved. | User Agreement | Privacy Policy | Contact